Please assess the completion status of the following clinical trial:

Trial Title: Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects are eligible for this trial if they satisfy all of the following criteria:~  * Patient is 18 to 65 years of age, inclusive~ * Patient is skeletally mature~ * Patient qualifies for primary unilateral or bilateral total hip arthroplasty based on physical exam and medical history including at least one of the following:~ * Osteoarthritis~ * Avascular necrosis~ * Rheumatoid arthritis~ * Correction of functional deformity~ * Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques~ * Patient has no history of previous total hip arthroplasty or arthrodesis of the affected hip joint(s)~ * Patient is willing and able to complete scheduled follow-up evaluations as described in the Informed Consent~ * Patient, or the patient's legally authorized representative, has participated in the Informed Consent process and is willing and able to sign an IRB- approved informed consent~Exclusion Criteria:~* Subjects will be excluded from this trial if they satisfy any of the following criteria as determined by the research staff or in the judgment of the treating physician:~  * Patient has a total prosthetic hip replacement device (including surface replacement arthroplasty, endoprosthesis, etc.) in the affected hip joint(s)~ * Patient is septic or has an active infection~ * Patient is uncooperative patient or is incapable of following directions~ * Patient is diagnosed with osteoporosis~ * Patient is diagnosed with a metabolic disorder which may impair bone formation~ * Patient is diagnosed with osteomalacia~ * Patient has distant foci of infections which may spread to the implant site

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).